Patient
P2B-054
completed Phase IIA Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma · Curie Manavata Cancer Centre (Nashik, India) (Dr. Nolan)
consented 2012-11-27
Adverse events
4
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 4
Grade 1 asthenia with onset in cycle 3 (2013-01-31); assessed as not related to study drug (unlikely); not resolved at last follow-up.
Grade 1 blood alkaline phosphatase increased with onset in cycle 2 (2013-01-17); assessed as not related to study drug (unlikely); resolved 2013-02-16.
Grade 1 stomatitis with onset in cycle 1 (2012-12-12); assessed as related to study drug (probable); resolved 2012-12-19.
Grade 1 constipation with onset in cycle 1 (2012-12-09); assessed as not related to study drug (unlikely); resolved 2012-12-13.
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.